The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-14.8% to $90.00
Predicted High$107.50at 1 month
Predicted Low$90.00at 6 months
Max Drawdown (predicted)-14.8%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 8, 2026 12:54 am
Bear
SBUX trends lower to
$90.00
(-14.8% from $105.59)
by Feb 2027.
ride-then-fade
ThesisNiccol turnaround narrative and recent Q3 comp beat sustain momentum near-term, but extreme valuation (composite FV ~$37 vs $105 price) and quality/forensic concerns exert gradual gravity over 6 months as story fatigue sets in without a scheduled catalyst.
Invalidated ifA confirmed re-acceleration in comps on next print or breakout above $115 on volume would invalidate the fade; conversely a break below $95 accelerates it.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $105.59 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 8, 2026
—
$105.59at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 22, 2026
$101.02–$110.16typical range · internal point $106.80
—
±4.3%
6/10
Momentum and risk-on regime carry recent strength
What actually happened:
closed $107.06
on Aug 21, 2026 = +1.4% vs the call
(predicted +1.2%)
· direction HIT
(called flat, was flat)
· off by 0.3 pp
· accuracy 10/10
· typical range ±4.3%:
inside the band
· S&P -1.1%
over the same window — beat it
1 month
Sep 8, 2026
$98.96–$112.22typical range · internal point $107.50
—
±6.3%
5/10
Narrative intact, no catalyst, drift higher
2 months
Oct 8, 2026
$104.00
—
-1.5%
4/10
Story fatigue begins as next print approaches
3 months
Nov 8, 2026
$100.50
—
-4.8%
5/10
Valuation gravity meets pre-earnings de-risking
4 months
Dec 8, 2026
$97.00
—
-8.1%
5/10
Post-print reality check on mature-brand growth
5 months
Jan 8, 2027
$93.50
—
-11.4%
5/10
Quality and forensic concerns pressure multiple
6 months
Feb 8, 2027
$90.00
—
-14.8%
5/10
Continued mean reversion toward deserved value
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$80.15
(-24.1%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.